| Full List of Metabolite(s) Regulated by This Protein |
| Nucleosides, nucleotides, and analogues |
| 3'-AMP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3'-AMP concentration: decrease (Log2 FC=0.58) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 3'-AMP levels compared with control group. |
| 3'-O-Methyladenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3'-O-Methyladenosine concentration: increase (Log2 FC=7.29) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 3'-o-methyladenosine levels compared with control group. |
| 5'-Methylthioadenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
5'-Methylthioadenosine concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 5'-methylthioadenosine levels compared with control group. |
| 5,2'-O-Dimethyluridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
5,2'-O-Dimethyluridine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 5,2'-o-dimethyluridine levels compared with control group. |
| 5-Thymidylic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
5-Thymidylic acid concentration: decrease (Log2 FC=0.64) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 5-thymidylic acid levels compared with control group. |
| 7-Methylguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
7-Methylguanosine concentration: increase (Log2 FC=1.2) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 7-methylguanosine levels compared with control group. |
| Adenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Adenosine concentration: increase (Log2 FC=5.97) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of adenosine levels compared with control group. |
| ADP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
ADP concentration: decrease (Log2 FC=0.91) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of ADP levels compared with control group. |
| AICA-riboside |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
AICA-riboside concentration: decrease (Log2 FC=0.19) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of AICA-riboside levels compared with control group. |
| AICAR |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
AICAR concentration: decrease (Log2 FC=0.27) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of AICAR levels compared with control group. |
| Allopurinol riboside |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Allopurinol riboside concentration: increase (Log2 FC=14.06) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of allopurinol riboside levels compared with control group. |
| CMP-N-Acetylneuraminate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
CMP-N-Acetylneuraminate concentration: increase (Log2 FC=1.34) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of CMP-N-acetylneuraminate levels compared with control group. |
| Cyclic AMP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cyclic AMP concentration: increase (Log2 FC=2.45) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cyclic AMP levels compared with control group. |
| Cytidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cytidine concentration: increase (Log2 FC=7.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cytidine levels compared with control group. |
| Cytidine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cytidine monophosphate concentration: decrease (Log2 FC=0.74) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of cytidine monophosphate levels compared with control group. |
| Cytidine-5'-diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cytidine-5'-diphosphate concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cytidine-5'-diphosphate levels compared with control group. |
| Deoxyadenosine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Deoxyadenosine monophosphate concentration: increase (Log2 FC=1.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of deoxyadenosine monophosphate levels compared with control group. |
| Deoxyguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Deoxyguanosine concentration: increase (Log2 FC=2.47) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of deoxyguanosine levels compared with control group. |
| Deoxyinosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Deoxyinosine concentration: increase (Log2 FC=2.37) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of deoxyinosine levels compared with control group. |
| Deoxyuridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Deoxyuridine concentration: increase (Log2 FC=3.23) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of deoxyuridine levels compared with control group. |
| Dephospho-CoA |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Dephospho-CoA concentration: decrease (Log2 FC=0.58) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of dephospho-CoA levels compared with control group. |
| Diadenosine tetraphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Diadenosine tetraphosphate concentration: increase (Log2 FC=1.1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of diadenosine tetraphosphate levels compared with control group. |
| FAD |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
FAD concentration: decrease (Log2 FC=0.85) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of FAD levels compared with control group. |
| Flavin mononucleotide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Flavin mononucleotide concentration: decrease (Log2 FC=0.73) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of flavin mononucleotide levels compared with control group. |
| Guanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Guanosine concentration: increase (Log2 FC=10.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of guanosine levels compared with control group. |
| Guanosine diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Guanosine diphosphate concentration: increase (Log2 FC=1.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of guanosine diphosphate levels compared with control group. |
| Guanosine diphosphate mannose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Guanosine diphosphate mannose concentration: decrease (Log2 FC=0.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of guanosine diphosphate mannose levels compared with control group. |
| Guanosine monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Guanosine monophosphate concentration: decrease (Log2 FC=0.56) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of guanosine monophosphate levels compared with control group. |
| Inosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Inosine concentration: increase (Log2 FC=9.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of inosine levels compared with control group. |
| Inosinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Inosinic acid concentration: decrease (Log2 FC=0.74) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of inosinic acid levels compared with control group. |
| N2,N2-Dimethylguanosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N2,N2-Dimethylguanosine concentration: decrease (Log2 FC=0.84) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N2,N2-dimethylguanosine levels compared with control group. |
| N6-Methyladenosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N6-Methyladenosine concentration: increase (Log2 FC=1.98) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N6-methyladenosine levels compared with control group. |
| NAD |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
NAD concentration: increase (Log2 FC=1.37) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of NAD levels compared with control group. |
| NADP |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
NADP concentration: decrease (Log2 FC=0.99) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of NADP levels compared with control group. |
| Nicotinamide ribotide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Nicotinamide ribotide concentration: increase (Log2 FC=1.38) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of nicotinamide ribotide levels compared with control group. |
| Phosphoadenosine phosphosulfate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phosphoadenosine phosphosulfate concentration: decrease (Log2 FC=0.98) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phosphoadenosine phosphosulfate levels compared with control group. |
| Riboprine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Riboprine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of riboprine levels compared with control group. |
| Ribothymidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Ribothymidine concentration: decrease (Log2 FC=0.35) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of ribothymidine levels compared with control group. |
| S-Adenosylhomocysteine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
S-Adenosylhomocysteine concentration: increase (Log2 FC=1.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of s-adenosylhomocysteine levels compared with control group. |
| S-Adenosylmethionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
S-Adenosylmethionine concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of s-adenosylmethionine levels compared with control group. |
| Thymidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Thymidine concentration: increase (Log2 FC=5.4) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of thymidine levels compared with control group. |
| UDP glucose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
UDP glucose concentration: decrease (Log2 FC=0.84) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of UDP glucose levels compared with control group. |
| UDP-N-acetylglucosamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
UDP-N-acetylglucosamine concentration: increase (Log2 FC=1.05) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of UDP-N-acetylglucosamine levels compared with control group. |
| Uridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uridine concentration: increase (Log2 FC=1.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of uridine levels compared with control group. |
| Uridine 5'-diphosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uridine 5'-diphosphate concentration: decrease (Log2 FC=0.77) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of uridine 5'-diphosphate levels compared with control group. |
| Uridine 5'-monophosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uridine 5'-monophosphate concentration: decrease (Log2 FC=0.38) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of uridine 5'-monophosphate levels compared with control group. |
| Uridine diphosphategalactose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uridine diphosphategalactose concentration: decrease (Log2 FC=0.87) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of uridine diphosphategalactose levels compared with control group. |
| Xanthosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Xanthosine concentration: increase (Log2 FC=5.92) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of xanthosine levels compared with control group. |
| Benzenoids |
| Adenylsuccinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Adenylsuccinic acid concentration: decrease (Log2 FC=0.57) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of adenylsuccinic acid levels compared with control group. |
| Dopamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Dopamine concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of dopamine levels compared with control group. |
| Lumichrome |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lumichrome concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of lumichrome levels compared with control group. |
| Norepinephrine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Norepinephrine concentration: increase (Log2 FC=1.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of norepinephrine levels compared with control group. |
| Phthalic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phthalic acid concentration: decrease (Log2 FC=0.81) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phthalic acid levels compared with control group. |
| Proglumide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Proglumide concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of proglumide levels compared with control group. |
| Salicyluric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Salicyluric acid concentration: increase (Log2 FC=1.04) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of salicyluric acid levels compared with control group. |
| Tyramine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Tyramine concentration: decrease (Log2 FC=0.79) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of tyramine levels compared with control group. |
| Lipid-related molecules |
| Erucamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Erucamide concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of erucamide levels compared with control group. |
| Lipids and lipid-like molecules |
| (E)-4-Hexen-1-ol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
(E)-4-Hexen-1-ol concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of (E)-4-hexen-1-ol levels compared with control group. |
| 1-Octadecenoyl-sn-glycero-3-phosphoethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
1-Octadecenoyl-sn-glycero-3-phosphoethanolamine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 1-octadecenoyl-sn-glycero-3-phosphoethanolamine levels compared with control group. |
| 1-Oleoyl-sn-glycerol 3-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
1-Oleoyl-sn-glycerol 3-phosphate concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 1-oleoyl-sn-glycerol 3-phosphate levels compared with control group. |
| 2-Methyl-3-hydroxybutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2-Methyl-3-hydroxybutyric acid concentration: increase (Log2 FC=1.08) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 2-methyl-3-hydroxybutyric acid levels compared with control group. |
| 2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) levels compared with control group. |
| 3-Hydroxymethylglutaric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Hydroxymethylglutaric acid concentration: increase (Log2 FC=1.58) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 3-hydroxymethylglutaric acid levels compared with control group. |
| 7-Ketocholesterol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
7-Ketocholesterol concentration: decrease (Log2 FC=0.83) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 7-ketocholesterol levels compared with control group. |
| Azelaic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Azelaic acid concentration: increase (Log2 FC=1.37) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of azelaic acid levels compared with control group. |
| Cholesterol sulfate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cholesterol sulfate concentration: increase (Log2 FC=1.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cholesterol sulfate levels compared with control group. |
| Glycerol 3-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycerol 3-phosphate concentration: decrease (Log2 FC=0.52) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glycerol 3-phosphate levels compared with control group. |
| Glycerophosphocholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycerophosphocholine concentration: increase (Log2 FC=1.47) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of glycerophosphocholine levels compared with control group. |
| Glycerophosphorylethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycerophosphorylethanolamine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glycerophosphorylethanolamine levels compared with control group. |
| L-Acetylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
L-Acetylcarnitine concentration: decrease (Log2 FC=0.73) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of L-acetylcarnitine levels compared with control group. |
| L-alpha-Phosphatidylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
L-alpha-Phosphatidylcholine concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of L-alpha-Phosphatidylcholine levels compared with control group. |
| L-Palmitoylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
L-Palmitoylcarnitine concentration: decrease (Log2 FC=0.33) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of L-palmitoylcarnitine levels compared with control group. |
| Linoelaidic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Linoelaidic acid concentration: increase (Log2 FC=1.48) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of linoelaidic acid levels compared with control group. |
| LysoPC(16:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
LysoPC(16:0/0:0) concentration: decrease (Log2 FC=0.42) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(16:0/0:0) levels compared with control group. |
| LysoPC(18:1(9Z)) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
LysoPC(18:1(9Z)) concentration: decrease (Log2 FC=0.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(18:1(9Z)) levels compared with control group. |
| LysoPC(22:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
LysoPC(22:0/0:0) concentration: decrease (Log2 FC=0.38) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysoPC(22:0/0:0) levels compared with control group. |
| Mesaconic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Mesaconic acid concentration: increase (Log2 FC=1.09) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of mesaconic acid levels compared with control group. |
| MG(14:0/0:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
MG(14:0/0:0/0:0) concentration: decrease (Log2 FC=0.39) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of MG(14:0/0:0/0:0) levels compared with control group. |
| MG(16:0/0:0/0:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
MG(16:0/0:0/0:0) concentration: decrease (Log2 FC=0.27) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of MG(16:0/0:0/0:0) levels compared with control group. |
| PC(16:0/16:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
PC(16:0/16:0) concentration: increase (Log2 FC=2.85) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of PC(16:0/16:0) levels compared with control group. |
| PC(18:1(9Z)/18:1(9Z)) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
PC(18:1(9Z)/18:1(9Z)) concentration: increase (Log2 FC=1.41) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of PC(18:1(9Z)/18:1(9Z)) levels compared with control group. |
| Platelet-activating factor |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Platelet-activating factor concentration: decrease (Log2 FC=0.33) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of platelet-activating factor levels compared with control group. |
| Sphingomyelin (d18:0/16:0) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Sphingomyelin (d18:0/16:0) concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of sphingomyelin (d18:0/16:0) levels compared with control group. |
| Stearoylcarnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Stearoylcarnitine concentration: decrease (Log2 FC=0.73) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of stearoylcarnitine levels compared with control group. |
| Nucleosides/nucleotides |
| 2'-O-Methylinosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2'-O-Methylinosine concentration: increase |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 2'-o-Methylinosine levels compared with control group. |
| Organic acids and derivatives |
| (S)-2-Formylamino-4-methylsulfanylbutanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
(S)-2-Formylamino-4-methylsulfanylbutanoic acid concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of (S)-2-formylamino-4-methylsulfanylbutanoic acid levels compared with control group. |
| 2,4-Diaminobutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2,4-Diaminobutyric acid concentration: decrease (Log2 FC=0.61) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 2,4-diaminobutyric acid levels compared with control group. |
| 2-Aminohexanedioic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2-Aminohexanedioic acid concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 2-aminohexanedioic acid levels compared with control group. |
| 3-Hydroxydodecanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Hydroxydodecanoic acid concentration: increase (Log2 FC=1.54) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 3-hydroxydodecanoic acid levels compared with control group. |
| 3-Methylhistidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Methylhistidine concentration: decrease (Log2 FC=0.95) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 3-methylhistidine levels compared with control group. |
| 3-Nitrotyrosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Nitrotyrosine concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 3-nitrotyrosine levels compared with control group. |
| 4-Guanidinobutanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
4-Guanidinobutanoic acid concentration: increase (Log2 FC=1.51) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 4-guanidinobutanoic acid levels compared with control group. |
| 5-Aminopentanoic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
5-Aminopentanoic acid concentration: increase (Log2 FC=1.09) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 5-aminopentanoic acid levels compared with control group. |
| Acamprosate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Acamprosate concentration: increase (Log2 FC=1.1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of acamprosate levels compared with control group. |
| Alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Alanine concentration: increase (Log2 FC=1.01) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of alanine levels compared with control group. |
| Alanylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Alanylglycine concentration: decrease (Log2 FC=0.89) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of alanylglycine levels compared with control group. |
| Alpha-Ketoisovaleric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Alpha-Ketoisovaleric acid concentration: increase (Log2 FC=1.54) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of alpha-Ketoisovaleric acid levels compared with control group. |
| Anserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Anserine concentration: decrease (Log2 FC=0.59) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of anserine levels compared with control group. |
| Arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Arginine concentration: decrease (Log2 FC=0.86) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of arginine levels compared with control group. |
| Argininosuccinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Argininosuccinic acid concentration: decrease (Log2 FC=0.71) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of argininosuccinic acid levels compared with control group. |
| Arginylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Arginylalanine concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of arginylalanine levels compared with control group. |
| Arginylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Arginylaspartic acid concentration: decrease (Log2 FC=0.81) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of arginylaspartic acid levels compared with control group. |
| Arginylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Arginylvaline concentration: increase (Log2 FC=1.17) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of arginylvaline levels compared with control group. |
| Asparagine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Asparagine concentration: increase (Log2 FC=1.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of asparagine levels compared with control group. |
| Aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Aspartic acid concentration: decrease (Log2 FC=0.57) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of aspartic acid levels compared with control group. |
| Asymmetric dimethylarginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Asymmetric dimethylarginine concentration: decrease (Log2 FC=0.81) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of asymmetric dimethylarginine levels compared with control group. |
| Betaine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Betaine concentration: increase (Log2 FC=1.81) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of betaine levels compared with control group. |
| Carnosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Carnosine concentration: decrease (Log2 FC=0.64) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of carnosine levels compared with control group. |
| Ciliatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Ciliatine concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of ciliatine levels compared with control group. |
| cis-Aconitic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
cis-Aconitic acid concentration: increase (Log2 FC=1.18) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cis-aconitic acid levels compared with control group. |
| Citric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Citric acid concentration: increase (Log2 FC=1.28) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of citric acid levels compared with control group. |
| Citrulline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Citrulline concentration: decrease (Log2 FC=0.78) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of citrulline levels compared with control group. |
| Creatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Creatine concentration: decrease (Log2 FC=0.62) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of creatine levels compared with control group. |
| Creatinine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Creatinine concentration: decrease (Log2 FC=0.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of creatinine levels compared with control group. |
| Cyclopropanecarboxylic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cyclopropanecarboxylic acid concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of cyclopropanecarboxylic acid levels compared with control group. |
| Cysteinylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cysteinylglycine concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of cysteinylglycine levels compared with control group. |
| D-Aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Aspartic acid concentration: increase (Log2 FC=1.19) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of D-aspartic acid levels compared with control group. |
| D-Ornithine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Ornithine concentration: decrease (Log2 FC=0.68) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-Ornithine levels compared with control group. |
| D-Pipecolic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Pipecolic acid concentration: increase (Log2 FC=1.22) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of D-Pipecolic acid levels compared with control group. |
| D-Proline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Proline concentration: decrease (Log2 FC=0.57) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-Proline levels compared with control group. |
| D-Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Serine concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-Serine levels compared with control group. |
| Edetic Acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Edetic Acid concentration: decrease (Log2 FC=0.19) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of edetic Acid levels compared with control group. |
| Epsilon-(gamma-Glutamyl)lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
epsilon-(gamma-Glutamyl)lysine concentration: decrease (Log2 FC=0.86) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of epsilon-(gamma-Glutamyl)lysine levels compared with control group. |
| Folic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Folic acid concentration: increase (Log2 FC=1.03) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of folic acid levels compared with control group. |
| Gamma-Aminobutyric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Aminobutyric acid concentration: increase (Log2 FC=2.13) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of gamma-aminobutyric acid levels compared with control group. |
| Gamma-Glutamylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Glutamylalanine concentration: decrease (Log2 FC=0.9) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylalanine levels compared with control group. |
| Gamma-Glutamylcysteine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Glutamylcysteine concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylcysteine levels compared with control group. |
| Gamma-Glutamylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Glutamylglutamic acid concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of gamma-glutamylglutamic acid levels compared with control group. |
| Gamma-Glutamylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Glutamylphenylalanine concentration: increase (Log2 FC=1.06) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of gamma-Glutamylphenylalanine levels compared with control group. |
| Gamma-Glutamylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Glutamylvaline concentration: increase (Log2 FC=1.26) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of gamma-glutamylvaline levels compared with control group. |
| Glutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutamic acid concentration: decrease (Log2 FC=0.87) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glutamic acid levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutamic acid concentration: increase (Log2 FC=1.1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of glutamic acid levels compared with control group. |
| Glutamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutamine concentration: decrease (Log2 FC=0.64) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glutamine levels compared with control group. |
| Glutamyllysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutamyllysine concentration: decrease (Log2 FC=0.94) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glutamyllysine levels compared with control group. |
| Glutamylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutamylproline concentration: increase (Log2 FC=1.09) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of glutamylproline levels compared with control group. |
| Glycyl-Glutamate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycyl-Glutamate concentration: decrease (Log2 FC=0.81) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glycyl-glutamate levels compared with control group. |
| Glycyl-Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycyl-Isoleucine concentration: increase (Log2 FC=1.65) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of glycyl-Isoleucine levels compared with control group. |
| Glycylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glycylproline concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glycylproline levels compared with control group. |
| Histidine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Histidine concentration: increase (Log2 FC=1.14) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of histidine levels compared with control group. |
| Histidylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Histidylaspartic acid concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of histidylaspartic acid levels compared with control group. |
| Histidylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Histidylglutamic acid concentration: increase (Log2 FC=1.55) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of histidylglutamic acid levels compared with control group. |
| Histidylisoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Histidylisoleucine concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of histidylisoleucine levels compared with control group. |
| Histidylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Histidylproline concentration: decrease (Log2 FC=0.55) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of histidylproline levels compared with control group. |
| Hypotaurine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Hypotaurine concentration: decrease (Log2 FC=0.7) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of hypotaurine levels compared with control group. |
| Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Isoleucine concentration: decrease (Log2 FC=0.84) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of isoleucine levels compared with control group. |
| Isoleucyl-Isoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Isoleucyl-Isoleucine concentration: increase (Log2 FC=1.07) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of isoleucyl-isoleucine levels compared with control group. |
| Isoleucyl-Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Isoleucyl-Methionine concentration: decrease (Log2 FC=0.7) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of isoleucyl-Methionine levels compared with control group. |
| L-Targinine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
L-Targinine concentration: increase (Log2 FC=1.32) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of L-targinine levels compared with control group. |
| Lactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lactic acid concentration: increase (Log2 FC=1.36) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of lactic acid levels compared with control group. |
| Leucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Leucine concentration: decrease (Log2 FC=0.85) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of leucine levels compared with control group. |
| Lysylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lysylaspartic acid concentration: decrease (Log2 FC=0.63) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysylaspartic acid levels compared with control group. |
| Lysylleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lysylleucine concentration: decrease (Log2 FC=0.89) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysylleucine levels compared with control group. |
| Lysylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lysylphenylalanine concentration: increase (Log2 FC=1.01) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of lysylphenylalanine levels compared with control group. |
| Lysylserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lysylserine concentration: decrease (Log2 FC=0.99) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of lysylserine levels compared with control group. |
| Lysylvaline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Lysylvaline concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of lysylvaline levels compared with control group. |
| Maleic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Maleic acid concentration: decrease (Log2 FC=0.86) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of maleic acid levels compared with control group. |
| Malic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Malic acid concentration: increase (Log2 FC=1.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of malic acid levels compared with control group. |
| Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Methionine concentration: decrease (Log2 FC=0.69) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of methionine levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Methionine concentration: increase (Log2 FC=2.87) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of methionine levels compared with control group. |
| N(6)-Methyllysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N(6)-Methyllysine concentration: increase (Log2 FC=1.29) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N(6)-methyllysine levels compared with control group. |
| N-a-Acetyl-L-arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-a-Acetyl-L-arginine concentration: increase (Log2 FC=1.31) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-a-acetyl-L-arginine levels compared with control group. |
| N-Acetyl-L-alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-L-alanine concentration: decrease (Log2 FC=0.68) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-L-alanine levels compared with control group. |
| N-Acetyl-L-aspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-L-aspartic acid concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-L-aspartic acid levels compared with control group. |
| N-Acetyl-L-glutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-L-glutamic acid concentration: increase (Log2 FC=2.7) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-L-glutamic acid levels compared with control group. |
| N-Acetylaspartylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylaspartylglutamic acid concentration: increase (Log2 FC=1.06) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-acetylaspartylglutamic acid levels compared with control group. |
| N-Acetylcadaverine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylcadaverine concentration: decrease (Log2 FC=0.34) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylcadaverine levels compared with control group. |
| N-Acetylglutamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylglutamine concentration: decrease (Log2 FC=0.59) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylglutamine levels compared with control group. |
| N-acetylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-acetylglycine concentration: decrease (Log2 FC=0.71) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylglycine levels compared with control group. |
| N-Acetylputrescine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylputrescine concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylputrescine levels compared with control group. |
| N6,N6,N6-Trimethyl-L-lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N6,N6,N6-Trimethyl-L-lysine concentration: decrease (Log2 FC=0.83) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N6,N6,N6-Trimethyl-L-lysine levels compared with control group. |
| N6-Acetyl-L-lysine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N6-Acetyl-L-lysine concentration: decrease (Log2 FC=0.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N6-acetyl-L-lysine levels compared with control group. |
| O-Phosphoethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
O-Phosphoethanolamine concentration: increase (Log2 FC=1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of o-phosphoethanolamine levels compared with control group. |
| Oxidized glutathione |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Oxidized glutathione concentration: decrease (Log2 FC=0.62) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of oxidized glutathione levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Oxidized glutathione concentration: increase (Log2 FC=1.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of oxidized glutathione levels compared with control group. |
| Phenylacetylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylacetylglycine concentration: increase (Log2 FC=1.01) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of phenylacetylglycine levels compared with control group. |
| Phenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylalanine concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phenylalanine levels compared with control group. |
| Phenylalanylglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylalanylglutamic acid concentration: increase (Log2 FC=1.44) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylglutamic acid levels compared with control group. |
| Phenylalanylproline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylalanylproline concentration: decrease (Log2 FC=0.67) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phenylalanylproline levels compared with control group. |
| Phenylalanylserine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylalanylserine concentration: increase (Log2 FC=1.1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylserine levels compared with control group. |
| Phenylalanylthreonine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenylalanylthreonine concentration: increase (Log2 FC=7.37) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of phenylalanylthreonine levels compared with control group. |
| Phosphocreatine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phosphocreatine concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phosphocreatine levels compared with control group. |
| Proline |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Proline concentration: decrease (Log2 FC=0.92) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of proline levels compared with control group. |
| Prolyl-Alanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Alanine concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-alanine levels compared with control group. |
| Prolyl-Arginine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Arginine concentration: increase (Log2 FC=1.29) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of prolyl-arginine levels compared with control group. |
| Prolyl-Asparagine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Asparagine concentration: increase (Log2 FC=1.27) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of prolyl-asparagine levels compared with control group. |
| Prolyl-Aspartate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Aspartate concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-aspartate levels compared with control group. |
| Prolyl-Glutamate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Glutamate concentration: decrease (Log2 FC=0.97) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-glutamate levels compared with control group. |
| Prolyl-Methionine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Methionine concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-methionine levels compared with control group. |
| Prolyl-Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Serine concentration: decrease (Log2 FC=0.88) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolyl-serine levels compared with control group. |
| Prolyl-Valine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolyl-Valine concentration: increase (Log2 FC=1.1) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of prolyl-valine levels compared with control group. |
| Prolylglycine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolylglycine concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of prolylglycine levels compared with control group. |
| Prolylphenylalanine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Prolylphenylalanine concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of prolylphenylalanine levels compared with control group. |
| Pyroglutamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pyroglutamic acid concentration: decrease (Log2 FC=0.5) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pyroglutamic acid levels compared with control group. |
| S-Lactoylglutathione |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
S-Lactoylglutathione concentration: increase (Log2 FC=1.55) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of s-lactoylglutathione levels compared with control group. |
| Saccharopine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Saccharopine concentration: decrease (Log2 FC=0.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of saccharopine levels compared with control group. |
| Sarcosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Sarcosine concentration: decrease (Log2 FC=0.73) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of sarcosine levels compared with control group. |
| Serine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Serine concentration: increase (Log2 FC=1.27) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of serine levels compared with control group. |
| Succinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Succinic acid concentration: increase (Log2 FC=1.03) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of succinic acid levels compared with control group. |
| Taurine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Taurine concentration: decrease (Log2 FC=0.6) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of taurine levels compared with control group. |
| Threonine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Threonine concentration: decrease (Log2 FC=0.66) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of threonine levels compared with control group. |
| Threonylaspartic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Threonylaspartic acid concentration: decrease (Log2 FC=0.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of threonylaspartic acid levels compared with control group. |
| Tyrosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Tyrosine concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of tyrosine levels compared with control group. |
| Valine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Valine concentration: decrease (Log2 FC=0.89) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of valine levels compared with control group. |
| Valylisoleucine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Valylisoleucine concentration: decrease (Log2 FC=0.7) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of valylisoleucine levels compared with control group. |
| Organic nitrogen compounds |
| Acetylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Acetylcholine concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of acetylcholine levels compared with control group. |
| Betaine aldehyde |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Betaine aldehyde concentration: increase (Log2 FC=1.44) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of betaine aldehyde levels compared with control group. |
| Carnitine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Carnitine concentration: decrease (Log2 FC=0.92) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of carnitine levels compared with control group. |
| Cyclohexylammonium |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cyclohexylammonium concentration: decrease (Log2 FC=0.71) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of cyclohexylammonium levels compared with control group. |
| Diethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Diethanolamine concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of diethanolamine levels compared with control group. |
| Oleoylethanolamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Oleoylethanolamide concentration: decrease (Log2 FC=0.66) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of oleoylethanolamide levels compared with control group. |
| Phosphorylcholine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phosphorylcholine concentration: increase (Log2 FC=1.26) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of phosphorylcholine levels compared with control group. |
| Triethanolamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Triethanolamine concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of triethanolamine levels compared with control group. |
| Organic oxygen compounds |
| 1-Deoxy-D-xylulose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
1-Deoxy-D-xylulose 5-phosphate concentration: increase (Log2 FC=1.43) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 1-deoxy-D-xylulose 5-phosphate levels compared with control group. |
| 3-Phosphoglyceric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Phosphoglyceric acid concentration: increase (Log2 FC=1.29) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 3-phosphoglyceric acid levels compared with control group. |
| Acetyl-CoA |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Acetyl-CoA concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of acetyl-CoA levels compared with control group. |
| D-Erythrose 4-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Erythrose 4-phosphate concentration: increase (Log2 FC=1.23) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of D-erythrose 4-phosphate levels compared with control group. |
| D-Mannose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Mannose concentration: decrease (Log2 FC=0.87) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-Mannose levels compared with control group. |
| D-Ribose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Ribose 5-phosphate concentration: increase (Log2 FC=1.84) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of D-Ribose 5-phosphate levels compared with control group. |
| D-Threitol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Threitol concentration: decrease (Log2 FC=0.97) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-threitol levels compared with control group. |
| D-Xylitol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
D-Xylitol concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of D-xylitol levels compared with control group. |
| Deoxyribose 5-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Deoxyribose 5-phosphate concentration: increase (Log2 FC=1.07) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of deoxyribose 5-phosphate levels compared with control group. |
| Dihydroxyacetone phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Dihydroxyacetone phosphate concentration: increase (Log2 FC=3.12) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of dihydroxyacetone phosphate levels compared with control group. |
| Fucose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Fucose 1-phosphate concentration: increase (Log2 FC=1.03) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of fucose 1-phosphate levels compared with control group. |
| Galactinol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Galactinol concentration: decrease (Log2 FC=0.25) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of galactinol levels compared with control group. |
| Galactose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Galactose 1-phosphate concentration: decrease (Log2 FC=0.82) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of galactose 1-phosphate levels compared with control group. |
| Galacturonic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Galacturonic acid concentration: decrease (Log2 FC=0.95) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of galacturonic acid levels compared with control group. |
| Glucosamine 6-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glucosamine 6-phosphate concentration: decrease (Log2 FC=0.76) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glucosamine 6-phosphate levels compared with control group. |
| Glucose 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glucose 1-phosphate concentration: increase (Log2 FC=1.21) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of glucose 1-phosphate levels compared with control group. |
| Glutaral |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Glutaral concentration: decrease (Log2 FC=0.77) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of glutaral levels compared with control group. |
| Isomaltose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Isomaltose concentration: decrease (Log2 FC=0.48) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of isomaltose levels compared with control group. |
| Maltotriose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Maltotriose concentration: increase (Log2 FC=1.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of maltotriose levels compared with control group. |
| myo-Inositol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
myo-Inositol concentration: increase (Log2 FC=1.02) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of myo-inositol levels compared with control group. |
| N-Acetyl-D-Glucosamine 6-Phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-D-Glucosamine 6-Phosphate concentration: increase (Log2 FC=1.51) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-D-glucosamine 6-phosphate levels compared with control group. |
| N-Acetyl-glucosamine 1-phosphate |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-glucosamine 1-phosphate concentration: decrease (Log2 FC=0.65) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetyl-glucosamine 1-phosphate levels compared with control group. |
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetyl-glucosamine 1-phosphate concentration: increase (Log2 FC=1.53) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-acetyl-glucosamine 1-phosphate levels compared with control group. |
| N-Acetylmannosamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylmannosamine concentration: decrease (Log2 FC=0.96) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylmannosamine levels compared with control group. |
| N-Acetylneuraminic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylneuraminic acid concentration: decrease (Log2 FC=0.66) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of N-acetylneuraminic acid levels compared with control group. |
| Pantothenic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pantothenic acid concentration: decrease (Log2 FC=0.59) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pantothenic acid levels compared with control group. |
| Pectin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pectin concentration: decrease (Log2 FC=0.52) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pectin levels compared with control group. |
| Pyruvaldehyde |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pyruvaldehyde concentration: decrease (Log2 FC=0.9) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pyruvaldehyde levels compared with control group. |
| Trehalose |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Trehalose concentration: decrease (Log2 FC=0.26) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of trehalose levels compared with control group. |
| Organo heterocyclic compounds |
| L-beta-Homoproline hydrochloride |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
L-beta-Homoproline hydrochloride concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of L-beta-Homoproline hydrochloride levels compared with control group. |
| Methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of methyl 5-amino-4-carbamoyl-imidazole-1-carboxylate levels compared with control group. |
| Organoheterocyclic compounds |
| 2-Hydroxyadenine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2-Hydroxyadenine concentration: increase (Log2 FC=7.58) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of 2-hydroxyadenine levels compared with control group. |
| 2-Hydroxypyridine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
2-Hydroxypyridine concentration: decrease (Log2 FC=0.54) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 2-hydroxypyridine levels compared with control group. |
| 3-Hydrazono-1-methyl-1,3-dihydro-indol-2-one |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
3-Hydrazono-1-methyl-1,3-dihydro-indol-2-one concentration: decrease |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 3-hydrazono-1-methyl-1,3-dihydro-indol-2-one levels compared with control group. |
| Biopterin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Biopterin concentration: decrease (Log2 FC=0.61) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of biopterin levels compared with control group. |
| Caffeine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Caffeine concentration: increase (Log2 FC=5.84) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of caffeine levels compared with control group. |
| Cytosine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Cytosine concentration: increase (Log2 FC=1.24) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of cytosine levels compared with control group. |
| Dihydrothymine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Dihydrothymine concentration: decrease (Log2 FC=0.61) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of dihydrothymine levels compared with control group. |
| Dihydrouracil |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Dihydrouracil concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of dihydrouracil levels compared with control group. |
| Folinic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Folinic acid concentration: decrease (Log2 FC=0.86) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of folinic acid levels compared with control group. |
| Gamma-Butyrolactone |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Gamma-Butyrolactone concentration: increase (Log2 FC=1.3) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of gamma-Butyrolactone levels compared with control group. |
| Hypoxanthine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Hypoxanthine concentration: increase (Log2 FC=8.31) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of hypoxanthine levels compared with control group. |
| Imidazoleacetic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Imidazoleacetic acid concentration: increase (Log2 FC=1.09) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of imidazoleacetic acid levels compared with control group. |
| Indole |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Indole concentration: increase (Log2 FC=1.15) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of indole levels compared with control group. |
| Indolelactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Indolelactic acid concentration: increase (Log2 FC=2.45) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of indolelactic acid levels compared with control group. |
| N-Acetylserotonin |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
N-Acetylserotonin concentration: increase (Log2 FC=1.13) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of N-acetylserotonin levels compared with control group. |
| Niacinamide |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Niacinamide concentration: decrease (Log2 FC=0.55) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of niacinamide levels compared with control group. |
| Oxypurinol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Oxypurinol concentration: increase (Log2 FC=3.21) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of oxypurinol levels compared with control group. |
| Pyridoxal |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pyridoxal concentration: decrease (Log2 FC=0.65) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pyridoxal levels compared with control group. |
| Pyridoxine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Pyridoxine concentration: decrease (Log2 FC=0.55) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of pyridoxine levels compared with control group. |
| Quinaldine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Quinaldine concentration: increase (Log2 FC=1.89) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of quinaldine levels compared with control group. |
| Thiamine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Thiamine concentration: decrease (Log2 FC=0.93) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of thiamine levels compared with control group. |
| Thymine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Thymine concentration: increase (Log2 FC=1.76) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of thymine levels compared with control group. |
| Tryptophan |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Tryptophan concentration: decrease (Log2 FC=0.66) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of tryptophan levels compared with control group. |
| Tryptophol |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Tryptophol concentration: decrease (Log2 FC=0.64) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of tryptophol levels compared with control group. |
| Uracil |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uracil concentration: decrease (Log2 FC=0.5) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of uracil levels compared with control group. |
| Uric acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uric acid concentration: increase (Log2 FC=1.11) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of uric acid levels compared with control group. |
| Uridine diphosphate glucuronic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Uridine diphosphate glucuronic acid concentration: increase (Log2 FC=1.33) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of uridine diphosphate glucuronic acid levels compared with control group. |
| Urocanic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Urocanic acid concentration: decrease (Log2 FC=0.75) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of urocanic acid levels compared with control group. |
| Xanthine |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Xanthine concentration: increase (Log2 FC=4.49) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of xanthine levels compared with control group. |
| Phenylpropanoids and polyketides |
| 4-Hydroxycinnamic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
4-Hydroxycinnamic acid concentration: decrease (Log2 FC=0.8) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of 4-hydroxycinnamic acid levels compared with control group. |
| Hydroxyphenyllactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Hydroxyphenyllactic acid concentration: increase (Log2 FC=1.33) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of hydroxyphenyllactic acid levels compared with control group. |
| Mulberrofuran M |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Mulberrofuran M concentration: increase (Log2 FC=1.38) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the increase of mulberrofuran M levels compared with control group. |
| Phenyllactic acid |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
| Introduced Variation |
Knockout of TP53 |
| Induced Change |
Phenyllactic acid concentration: decrease (Log2 FC=0.72) |
| Summary |
Introduced Variation
Induced Change
|
| Disease Status |
Colon cancer [ICD-11: 2B90]
|
| Details |
It is reported that knockout of TP53 leads to the decrease of phenyllactic acid levels compared with control group. |
|
|
|
|
|
|
|